LYR-220, Lyra’s second product candidate, is a long-acting anti-inflammatory therapy in development for CRS patients with and without polyps who have recurrent symptoms despite prior ethmoid sinus ...

Ethmoid sinus cancer is a rare form of cancer that originates in the sinuses, behind the upper nose and between the eyes. Treatment might include surgery, chemotherapy, or radiation therapy. Although ...